CAR T-cell therapy trains your body’s T-cells -- a type of white blood cell -- to recognize and fight cancer. The cells are removed from your blood, re-engineered in a specialized manufacturing facility, and returned to your body through an infusion.
Conditions We Treat
CAR T-cell therapy is FDA-approved to treat relapsed refractory:
- B-cell acute lymphoblastic leukemia
- Mantle cell lymphoma
- Follicular lymphoma
- B-cell non-Hodgkin lymphoma
- Multiple myeloma
Learn how CAR T-cell therapy works.